Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Rivière Y[au]:

Efficiency of poly(A).poly(U) as an adjuvant. Hovanessian AG et al. Immunol Today. (1988)

Mapping arenavirus genes causing virulence. Riviere Y et al. Curr Top Microbiol Immunol. (1987)

The cellular immune response to the human immunodeficiency virus. Rivière Y et al. Curr Opin Immunol. (1989)

Search results

Items: 1 to 50 of 121

1.

Hepatitis C virus-specific cellular immune responses in individuals with no evidence of infection.

Rivière Y, Montange T, Janvier G, Marnata C, Durrieu L, Chaix ML, Isaguliants M, Launay O, Bresson JL, Pol S.

Virol J. 2012 Mar 28;9:76. doi: 10.1186/1743-422X-9-76.

2.

Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: the ANRS-EP38-IMMIP study.

Avettand-Fenoel V, Blanche S, Le Chenadec J, Scott-Algara D, Dollfus C, Viard JP, Bouallag N, Benmebarek Y, Rivière Y, Warszawski J, Rouzioux C, Buseyne F.

J Infect Dis. 2012 May 15;205(10):1520-8. doi: 10.1093/infdis/jis233. Epub 2012 Mar 15.

3.

Gamma(c) deficiency precludes CD8+ T cell memory despite formation of potent T cell effectors.

Decaluwe H, Taillardet M, Corcuff E, Munitic I, Law HK, Rocha B, Rivière Y, Di Santo JP.

Proc Natl Acad Sci U S A. 2010 May 18;107(20):9311-6. doi: 10.1073/pnas.0913729107. Epub 2010 May 3.

4.

In untreated HIV-1-infected children, PBMC-associated HIV DNA levels and cell-free HIV RNA levels are correlated to distinct T-lymphocyte populations.

Scott-Algara D, Rouzioux C, Blanche S, Burgard M, Didier C, Rivière Y, Buseyne F.

J Acquir Immune Defic Syndr. 2010 Apr;53(5):553-63. doi: 10.1097/QAI.0b013e3181cf060f.

5.

Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells.

Nascimbeni M, Montange T, Law HK, Mallet V, Saunier B, Rivière Y, Pol S.

Hepatology. 2010 Jan;51(1):353. doi: 10.1002/hep.23165. No abstract available.

PMID:
20034022
6.

Epitope specificity and relative clonal abundance do not affect CD8 differentiation patterns during lymphocytic choriomeningitis virus infection.

Munitic I, Decaluwe H, Evaristo C, Lemos S, Wlodarczyk M, Worth A, Le Bon A, Selin LK, Rivière Y, Di Santo JP, Borrow P, Rocha B.

J Virol. 2009 Nov;83(22):11795-807. doi: 10.1128/JVI.01402-09. Epub 2009 Sep 2.

7.

Poor recognition of HIV-1 Nef protein by CD8 T cells from HIV-1-infected children: impact of age.

Buseyne F, Scott-Algara D, Corre B, Porrot F, Monchatre E, Bellal N, Burgard M, Rouzioux C, Blanche S, Rivière Y.

Virology. 2006 Oct 25;354(2):271-9. Epub 2006 Aug 10.

8.

The frequency of HIV-specific interferon- gamma -producing CD8 T cells is associated with both age and level of antigenic stimulation in HIV-1-infected children.

Buseyne F, Scott-Algara D, Bellal N, Burgard M, Rouzioux C, Blanche S, Riviere Y.

J Infect Dis. 2005 Nov 15;192(10):1781-6. Epub 2005 Oct 7.

PMID:
16235177
10.

In HIV type 1-infected children cytotoxic T lymphocyte responses are associated with greater reduction of viremia under antiretroviral therapy.

Buseyne F, Le Chenadec J, Burgard M, Bellal N, Mayaux MJ, Rouzioux C, Rivière Y, Blanche S.

AIDS Res Hum Retroviruses. 2005 Aug;21(8):719-27.

PMID:
16131312
11.
13.

Loss of reactivity of vaccine-induced CD4 T cells in immunized monkeys after SIV/HIV challenge.

Puaux AL, Delache B, Marconi S, Huerre M, Le Grand R, Rivière Y, Michel ML.

AIDS. 2005 May 20;19(8):757-65.

PMID:
15867489
14.

A vaccinia-based elispot assay for detection of CD8+ T cells from HIV-1 infected children.

Buseyne F, Catteau A, Scott-Algara D, Corre B, Porrot F, Rouzioux C, Blanche S, Rivière Y.

J Immunol Methods. 2005 Mar;298(1-2):105-18.

PMID:
15847801
15.

Not all tetramer binding CD8+ T cells can produce cytokines and chemokines involved in the effector functions of virus-specific CD8+ T lymphocytes in HIV-1 infected children.

Scott-Algara D, Buseyne F, Porrot F, Corre B, Bellal N, Rouzioux C, Blanche S, Riviere Y.

J Clin Immunol. 2005 Jan;25(1):57-67.

PMID:
15742158
16.

Efficient priming of simian/human immunodeficiency virus (SHIV)-specific T-cell responses with DNA encoding hybrid SHIV/hepatitis B surface antigen particles.

Puaux AL, Marsac D, Prost S, Singh MK, Earl P, Moss B, Le Grand R, Riviere Y, Michel ML.

Vaccine. 2004 Sep 9;22(27-28):3535-45.

PMID:
15315833
17.

Functional characterization of human Tc0, Tc1 and Tc2 CD8+ T cell clones: control of X4 and R5 HIV strain replication.

Février M, le Borgne S, Marty C, Talarmin A, Rivière Y.

J Clin Immunol. 2004 May;24(3):272-80.

PMID:
15114057
18.

Kinetics of lymphocyte proliferation during primary immune response in macaques infected with pathogenic simian immunodeficiency virus SIVmac251: preliminary report of the effect of early antiviral therapy.

Benlhassan-Chahour K, Penit C, Dioszeghy V, Vasseur F, Janvier G, Rivière Y, Dereuddre-Bosquet N, Dormont D, Le Grand R, Vaslin B.

J Virol. 2003 Dec;77(23):12479-93.

19.

Extensive apoptosis in lymphoid organs during primary SIV infection predicts rapid progression towards AIDS.

Monceaux V, Estaquier J, Février M, Cumont MC, Rivière Y, Aubertin AM, Ameisen JC, Hurtrel B.

AIDS. 2003 Jul 25;17(11):1585-96.

PMID:
12853740
20.

Markov modelling of changes in HIV-specific cytotoxic T-lymphocyte responses with time in untreated HIV-1 infected patients.

Kousignian I, Autran B, Chouquet C, Calvez V, Gomard E, Katlama C, Rivière Y, Costagliola D; IMMUNOCO Study Group.

Stat Med. 2003 May 30;22(10):1675-90.

PMID:
12720304
21.

Early and late cytotoxic T lymphocyte responses in HIV infection.

Brander C, Rivière Y.

AIDS. 2002;16 Suppl 4:S97-103. Review. No abstract available.

PMID:
12699006
22.

Correlation between breadth of memory HIV-specific cytotoxic T cells, viral load and disease progression in HIV infection.

Chouquet C, Autran B, Gomard E, Bouley JM, Calvez V, Katlama C, Costagliola D, Rivière Y; IMMUNOCO Study Group.

AIDS. 2002 Dec 6;16(18):2399-407.

PMID:
12461413
23.

Inverse correlation between memory Gag-specific cytotoxic T lymphocytes and viral replication in human immunodeficiency virus-infected children.

Buseyne F, Le Chenadec J, Corre B, Porrot F, Burgard M, Rouzioux C, Blanche S, Mayaux MJ, Rivière Y.

J Infect Dis. 2002 Dec 1;186(11):1589-96. Epub 2002 Nov 1.

PMID:
12447734
24.

Frequencies of ex vivo-activated human immunodeficiency virus type 1-specific gamma-interferon-producing CD8+ T cells in infected children correlate positively with plasma viral load.

Buseyne F, Scott-Algara D, Porrot F, Corre B, Bellal N, Burgard M, Rouzioux C, Blanche S, Rivière Y.

J Virol. 2002 Dec;76(24):12414-22.

25.

Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus.

Favre D, Blouin V, Provost N, Spisek R, Porrot F, Bohl D, Marmé F, Chérel Y, Salvetti A, Hurtrel B, Heard JM, Rivière Y, Moullier P.

J Virol. 2002 Nov;76(22):11605-11.

26.

Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic, H-2 class I KO mice.

Firat H, Tourdot S, Ureta-Vidal A, Scardino A, Suhrbier A, Buseyne F, Rivìere Y, Danos O, Michel ML, Kosmatopoulos K, Lemonnier FA.

Eur J Immunol. 2001 Oct;31(10):3064-74.

27.
29.

A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity.

Lecoeur H, Février M, Garcia S, Rivière Y, Gougeon ML.

J Immunol Methods. 2001 Jul 1;253(1-2):177-87.

PMID:
11384679
30.

Frequency and phenotyping of human immunodeficiency virus (HIV)-specific CD8+ T cells in HIV-infected children, using major histocompatibility complex class I peptide tetramers.

Scott-Algara D, Buseyne F, Blanche S, Rouzioux C, Jouanne C, Romagné F, Rivière Y.

J Infect Dis. 2001 Jun 1;183(11):1565-73. Epub 2001 Apr 27.

PMID:
11343205
32.

Expansion of HBV-specific memory CTL primed by dual HIV/HBV genetic immunization during SHIV primary infection in rhesus macaques.

Borgne SL, Michel ML, Camugli S, Corre B, Le Grand R, Rivière Y.

Vaccine. 2001 Mar 21;19(17-19):2485-95.

PMID:
11257382
33.

MHC-I-restricted presentation of HIV-1 virion antigens without viral replication.

Buseyne F, Le Gall S, Boccaccio C, Abastado JP, Lifson JD, Arthur LO, Rivière Y, Heard JM, Schwartz O.

Nat Med. 2001 Mar;7(3):344-9.

PMID:
11231634
34.

Immune responses following simian/human immunodeficiency virus (SHIV) challenge of rhesus macaques after human immunodeficiency virus (HIV)-1 third variable domain (V3) loop-based genetic immunization.

Le Borgne S, Le Grand R, Michel ML, Vaslin B, Boson B, Janvier G, Aubertin AM, Dormont D, Rivière Y.

J Med Primatol. 2000 Dec;29(6):371-86.

PMID:
11168828
36.

Implication of the C-terminal domain of nef protein in the reversion to pathogenicity of attenuated SIVmacBK28-41 in macaques.

Lafont BA, Rivière Y, Gloeckler L, Beyer C, Hurtrel B, Paule Kieny M, Kirn A, Aubertin AM.

Virology. 2000 Jan 20;266(2):286-98.

37.

Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals.

Magierowska M, Theodorou I, Debré P, Sanson F, Autran B, Rivière Y, Charron D, Costagliola D.

Blood. 1999 Feb 1;93(3):936-41.

PMID:
9920843
38.

Early HIV-specific cytotoxic T lymphocytes and disease progression in children born to HIV-infected mothers.

Buseyne F, Burgard M, Teglas JP, Bui E, Rouzioux C, Mayaux MJ, Blanche S, Rivière Y.

AIDS Res Hum Retroviruses. 1998 Nov 1;14(16):1435-44.

PMID:
9824321
39.

Impact of heterozygosity for the chemokine receptor CCR5 32-bp-deleted allele on plasma virus load and CD4 T lymphocytes in perinatally human immunodeficiency virus-infected children at 8 years of age.

Buseyne F, Janvier G, Teglas JP, Ivanoff S, Burgard M, Bui E, Mayaux MJ, Blanche S, Rouzioux C, Rivière Y.

J Infect Dis. 1998 Oct;178(4):1019-23.

PMID:
9806029
40.

Cross-clade-specific cytotoxic T lymphocytes in HIV-1-infected children.

Buseyne F, Chaix ML, Fleury B, Manigart O, Burgard M, Blanche S, Rouzioux C, Rivière Y.

Virology. 1998 Oct 25;250(2):316-24. Erratum in: Virology. 2008 Mar 15;372(2):457. Manigard, O [corrected to Manigart, O].

41.

Cytotoxic T lymphocytes generation capacity in early life with particular reference to HIV.

Rivière Y, Buseyne F.

Vaccine. 1998 Aug-Sep;16(14-15):1420-2. Review.

PMID:
9711782
42.

In vivo induction of specific cytotoxic T lymphocytes in mice and rhesus macaques immunized with DNA vector encoding an HIV epitope fused with hepatitis B surface antigen.

Le Borgne S, Mancini M, Le Grand R, Schleef M, Dormont D, Tiollais P, Rivière Y, Michel ML.

Virology. 1998 Jan 20;240(2):304-15.

43.

Potential deleterious effect of anti-viral cytotoxic lymphocyte through the CD95 (FAS/APO-1)-mediated pathway during chronic HIV infection.

Garcia S, Fevrier M, Dadaglio G, Lecoeur H, Riviere Y, Gougeon ML.

Immunol Lett. 1997 Jun 1;57(1-3):53-8.

PMID:
9232425
44.

Characterization of an HIV-1 p24gag epitope recognized by a CD8+ cytotoxic T-cell clone.

Buseyne F, Stevanovic S, Rammensee HG, Rivière Y.

Immunol Lett. 1997 Mar;55(3):145-9. Erratum in: Immunol Lett 2001 Aug 1;78(1):55.

PMID:
9161880
45.

CD26 as a positive regulator of HIV envelope-glycoprotein induced apoptosis in CD4+ T cells.

Jacotot E, Callebaut C, Blanco J, Rivière Y, Krust B, Hovanessian AG.

Adv Exp Med Biol. 1997;421:207-16. Review.

PMID:
9330699
47.

Memory cytotoxic T lymphocyte responses in human immunodeficiency virus type 1 (HIV-1)-negative volunteers immunized with a recombinant canarypox expressing gp 160 of HIV-1 and boosted with a recombinant gp160.

Fleury B, Janvier G, Pialoux G, Buseyne F, Robertson MN, Tartaglia J, Paoletti E, Kieny MP, Excler JL, Rivière Y.

J Infect Dis. 1996 Oct;174(4):734-8.

PMID:
8843210
48.

HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells.

Jacotot E, Callebaut C, Blanco J, Rivière Y, Krust B, Hovanessian AG.

Virology. 1996 Sep 15;223(2):318-30.

49.

Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS.

Rivière Y, McChesney MB, Porrot F, Tanneau-Salvadori F, Sansonetti P, Lopez O, Pialoux G, Feuillie V, Mollereau M, Chamaret S, et al.

AIDS Res Hum Retroviruses. 1995 Aug;11(8):903-7.

PMID:
7492437
50.

Sequence constraints and recognition by CTL of an HLA-B27-restricted HIV-1 gag epitope.

Nietfield W, Bauer M, Fevrier M, Maier R, Holzwarth B, Frank R, Maier B, Riviere Y, Meyerhans A.

J Immunol. 1995 Mar 1;154(5):2189-97.

PMID:
7868892

Supplemental Content

Loading ...
Support Center